BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260803
DTEND;VALUE=DATE:20261013
DTSTAMP:20260720T142608Z
CREATED:20260720T142239Z
LAST-MODIFIED:20260720T142608Z
UID:10000802-1785715200-1791849599@oncodaily.com
SUMMARY:ESMO Academy 2026
DESCRIPTION:The ESMO Academy 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place virtually from 3 August to 12 October 2026. \nThe programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty\, covering major tumour types\, clinical trial methodology\, treatment principles\, pharmacokinetics\, drug interactions\, and topics relevant to the ESMO Examination. Access is initially limited to participants registered for the ESMO Examination 2026\, while the modules will become available to all ESMO members from November 2026. Registered participants will receive access details closer to the course start date.
URL:https://oncodaily.com/event/esmo-academy-2026-546719
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-06_21_08-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260826T080000
DTEND;TZID=America/Halifax:20260826T170000
DTSTAMP:20260826T114754Z
CREATED:20260826T114754Z
LAST-MODIFIED:20260826T114754Z
UID:10000955-1787731200-1787763600@oncodaily.com
SUMMARY:The 50th Brno Oncology Days
DESCRIPTION:The 50th Brno Oncology Days (BOD 2026) will take place on September 9–11\, 2026\, at the Brno Exhibition Centre in Brno\, Czech Republic. \nOrganized by the Masaryk Memorial Cancer Institute\, the anniversary edition will bring together oncology professionals for three days of multidisciplinary education\, scientific discussion\, and networking. \nThe programme will cover individual cancer types as well as young patients with cancer\, hereditary cancer syndromes\, oncology data\, telemedicine\, artificial intelligence\, prevention\, and organizational aspects of surgical care. \nThe meeting will also include International Brno Oncology Days\, with international experts such as Andrés Cervantes\, Nadia Harbeck\, and Elizabeth Smyth\, and sessions focused on areas including precision oncology and survivorship. The conference is ESMO accredited\, and online registration remains open until August 31\, 2026.
URL:https://oncodaily.com/event/50th-brno-oncology-days-574884
LOCATION:Brno Exhibition Centre\, Výstaviště 405/1\, Brno\, South Moravian Region\, 603 00\, Czech Republic
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/maxresdefault-4-1.webp
ORGANIZER;CN="Masaryk Memorial Cancer Institute":MAILTO:direct@mou.cz
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260902T183000
DTEND;TZID=America/Halifax:20260902T183000
DTSTAMP:20260721T141827Z
CREATED:20260721T141827Z
LAST-MODIFIED:20260721T141827Z
UID:10000808-1788373800-1788373800@oncodaily.com
SUMMARY:ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026
DESCRIPTION:The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar\, organized by the European Society for Medical Oncology (ESMO)\, will take place live on 2 September 2026 at 18:30 CEST. \nThe session will examine the reliability of current HRD testing\, the role of PARP inhibitors in maintenance therapy\, and the emerging potential of antibody–drug conjugates for patients with HRD-negative advanced ovarian cancer. Faculty include Isabelle L. Ray-Coquard\, Charlie Gourley\, Robert Louis Coleman\, and Kathleen Nadine Moore. Registration is available exclusively to ESMO members\, and live participants will receive a certificate of attendance and two ESMO-MORA Category 1 points. \nRegister Now.
URL:https://oncodaily.com/event/ovarian-cancer-2026-547749
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/pxbee_2026-07-21_18-11-08.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260909T183000
DTEND;TZID=America/Halifax:20260909T183000
DTSTAMP:20260826T115818Z
CREATED:20260826T115818Z
LAST-MODIFIED:20260826T115818Z
UID:10000956-1788978600-1788978600@oncodaily.com
SUMMARY:Optimising Antibody–Drug Conjugate Safety: Mechanisms\, Monitoring and Management of Toxicities 2026
DESCRIPTION:The “Optimising Antibody–Drug Conjugate Safety: Mechanisms\, Monitoring and Management of Toxicities 2026” webinar\, organized by the European Society for Medical Oncology (ESMO)\, will take place on September 9\, 2026\, at 6:30 PM CEST (8:30 PM AMT). \nPart of the ESMO Therapeutic Landscapes series\, the session will focus on recognising\, preventing\, and managing toxicities associated with antibody–drug conjugates (ADCs). The programme will address patient- and treatment-related risk factors\, supportive and preventive strategies\, and the mechanisms\, early recognition\, differential diagnosis\, grading\, and management of ADC-related interstitial lung disease and ocular toxicity. Practical issues such as treatment interruption\, corticosteroid use\, safe rechallenge\, and maintaining treatment continuity will also be discussed\, followed by an interactive Q&A. The webinar is chaired by Liliana Ascione\, MD.
URL:https://oncodaily.com/event/antibody-drug-conjugate-safety-574918
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-03_56_22-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260910
DTEND;VALUE=DATE:20260912
DTSTAMP:20251126T131416Z
CREATED:20251126T131341Z
LAST-MODIFIED:20251126T131416Z
UID:10000410-1788998400-1789171199@oncodaily.com
SUMMARY:Molecular Analysis for Precision Oncology Congress 2026
DESCRIPTION:The Molecular Analysis for Precision Oncology (MAP) Congress 2026\, co-organized by the European Society for Medical Oncology (ESMO)\, Cancer Research UK (CRUK)\, and Unicancer\, is scheduled for 10–11 September 2026 in London\, United Kingdom. \nThis high-level\, two-day meeting will serve as a platform for experts in oncology\, molecular diagnostics\, and precision medicine to converge and exchange ideas. \nThe primary focus of the congress is to share advances in cancer research\, strengthen interdisciplinary connections\, and accelerate the translation of molecular insights – particularly concerning molecular profiling\, biomarker discovery\, and personalized treatment strategies – into routine clinical practice to improve global patient care.
URL:https://oncodaily.com/event/precision-oncology-416782
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/MAP2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260918
DTEND;VALUE=DATE:20260920
DTSTAMP:20260126T222126Z
CREATED:20260126T222113Z
LAST-MODIFIED:20260126T222126Z
UID:10000627-1789689600-1789862399@oncodaily.com
SUMMARY:ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026: Zurich
DESCRIPTION:The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich\, Switzerland\, from September 18–19\, 2026. \nChaired by Natalie Cook and Benedikt Westphalen\, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases\, from diagnosis to treatment\, according to current standards of care. \nThe program focuses on the reshaping of cancer care through tumour-agnostic therapies andprecision oncology\, offering participants the opportunity to learn from leaders in the field while earning 10 ESMO-MORA category 1 points. Applications for the course open with a deadline of June 3\, 2026\, and successful applicants benefit from complimentary registration and accommodation.
URL:https://oncodaily.com/event/esmo-preceptorship-447566
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20260928
DTSTAMP:20260627T142318Z
CREATED:20260627T142318Z
LAST-MODIFIED:20260627T142318Z
UID:10000778-1790294400-1790553599@oncodaily.com
SUMMARY:European School of Oncology's Master in Sarcoma
DESCRIPTION:The ESO Master in Sarcoma is a 15-month academic programme developed by the European School of Oncology in collaboration with the Università Campus Bio-Medico di Roma\, designed to advance the clinical and scientific expertise of professionals working in sarcoma management. \nAwarding 60 ECTS credits upon completion\, the programme combines 10 online modules\, two in-person seminars\, an internship\, and a thesis. Participants are also eligible to enrol in ESO College. \n\nApplications opened: March 2026\nApplication deadline: 1 June 2026\nProgramme start: September 2026\nSeminar 1: 25–27 September 2026 — Rome\, Italy\nSeminar 2: March 2027 — ESMO Sarcoma and Rare Cancers Congress\, Lugano\, Switzerland
URL:https://oncodaily.com/event/sarcoma-529658
LOCATION:Università Campus Bio-Medico di Roma\, Via Álvaro del Portillo\, 21\, Rome\, 00128\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/d83fcce6fb63469c9eca24df586aa35a.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20270103
DTSTAMP:20260620T133549Z
CREATED:20260620T133549Z
LAST-MODIFIED:20260620T133549Z
UID:10000766-1790294400-1798934399@oncodaily.com
SUMMARY:European School of Oncology's Refresher Course on Sarcoma
DESCRIPTION:The European School of Oncology’s Refresher Course on Sarcoma is an advanced educational event taking place from 25 to 27 September 2026 in Rome\, Italy. \nOrganized in collaboration with the Università Campus Bio-Medico di Roma\, the program is led by Course Chair Sylvie Bonvalot (FR)\, Host Chair Bruno Vincenzi (IT)\, and College Representative Silvia Brotea-Mosoiu (RO). \nThe curriculum provides a comprehensive review of soft tissue sarcomas alongside bone\, desmoid\, pediatric\, GIST\, and uterine subtypes. It focuses directly on the WHO classification\, molecular biology\, advanced imaging\, biopsy techniques\, surgical quality standards\, and radiotherapy sequencing. Through interactive\, faculty-led clinical case discussions\, the course equips attending specialists with evidence-based strategies to optimize multidisciplinary decision-making and advance personalized patient care. \n 
URL:https://oncodaily.com/event/sarcoma-524499
LOCATION:Università Campus Bio-Medico di Roma\, Via Álvaro del Portillo\, 21\, Rome\, 00128\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/649120323_1236242505289553_8154662109148234054_n.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261001
DTSTAMP:20260721T145557Z
CREATED:20260721T145538Z
LAST-MODIFIED:20260721T145557Z
UID:10000809-1790640000-1790812799@oncodaily.com
SUMMARY:ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026
DESCRIPTION:The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 29–30 September 2026 in Lugano\, Switzerland. \nThe course will focus on managing cancer-related symptoms\, cachexia\, nutritional needs\, treatment toxicities\, palliative care\, end-of-life preparation\, and communication with patients and families. Applications close on 26 July 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 11 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodaily.com/event/cancer-patients-2026-547812
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-06_43_45-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
DTSTAMP:20260127T204424Z
CREATED:20260127T204408Z
LAST-MODIFIED:20260127T204424Z
UID:10000636-1790726400-1790812799@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday\, September 30\, 2026\, starting at 18:30 CEST. \nAs uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma\, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens of daily practice. \nChaired by Olivier Michielin\, the session features a multidisciplinary expert panel including Jorja Braden\, Sophie Piperno-Neumann\, Erick Saldanha\, and Mauricio Fernando Silva Almeida Ribeiro. The program focuses on translating recent breakthroughs – such as the efficacy of tebentafusp – into practical clinical strategies\, addressing implementation barriers\, and utilizing molecular profiling to optimize patient management. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-448014
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260930T183000
DTEND;TZID=America/Halifax:20260930T183000
DTSTAMP:20260826T121258Z
CREATED:20260826T121211Z
LAST-MODIFIED:20260826T121258Z
UID:10000957-1790793000-1790793000@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases – Early Stage and Locally Advanced NSCLC 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases Webinar – Early Stage and Locally Advanced NSCLC 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on September 30\, 2026\, at 6:30 PM CEST (8:30 PM AMT). \nThe webinar will review the latest evidence-based recommendations for early-stage and locally advanced non-small-cell lung cancer (NSCLC)\, with a particular focus on translating the ESMO Clinical Practice Guidelines into everyday clinical decision-making through discussion of a real-world patient case. \nThe expert session is designed to help participants critically assess guideline recommendations\, consider their practical implementation\, and apply current standards of care to multidisciplinary management of patients with potentially curable NSCLC. Participants attending the live webinar can earn 1 ESMO-MORA Category 1 point.
URL:https://oncodaily.com/event/esmo-guidelines-574931
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-04_10_40-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260721T160010Z
CREATED:20260721T160010Z
LAST-MODIFIED:20260721T160010Z
UID:10000811-1790899200-1791071999@oncodaily.com
SUMMARY:ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on treatment sequencing\, the biology of metastatic breast cancer\, targeted therapy safety and adverse-event management\, and multidisciplinary approaches to improving patient outcomes. Applications close on 21 August 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 10 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodaily.com/event/metastatic-breast-cancer-2026-547927
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-07_50_11-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260721T161206Z
CREATED:20260721T161206Z
LAST-MODIFIED:20260721T161206Z
UID:10000812-1790899200-1791071999@oncodaily.com
SUMMARY:ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC
DESCRIPTION:The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026\, oorganized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC\, biomarker-driven treatment using NGS\, immunohistochemistry\, and liquid biopsy\, and emerging therapies such as antibody–drug conjugates\, bispecific antibodies\, cellular therapies\, and vaccines. It will also address multidisciplinary management of oligometastatic disease and brain metastases. Applications close on 10 August 2026 at 23:59 CEST\, and non-local participants may receive a travel grant of up to €600. \nApply Now.
URL:https://oncodaily.com/event/advanced-nsclc-547940
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-08_06_59-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261007T183000
DTEND;TZID=America/Halifax:20261007T183000
DTSTAMP:20260826T122502Z
CREATED:20260826T122502Z
LAST-MODIFIED:20260826T122502Z
UID:10000958-1791397800-1791397800@oncodaily.com
SUMMARY:ESMO Deep Dive: The Evolving Landscape in Relapsed Ovarian Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Gynaecological Cancers – The Evolving Landscape in the Treatment of Relapsed Ovarian Cancer 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on October 7\, 2026\, at 6:30 PM CEST (8:30 PM AMT). \nThis live educational webinar will examine how new concepts and therapeutic strategies are reshaping the management of relapsed ovarian cancer\, with particular attention to evolving treatment classifications and the growing role of antibody–drug conjugates (ADCs). \nThe expert discussion will address how emerging therapies may be integrated and sequenced within current treatment pathways\, providing practical insights for clinicians managing patients with recurrent disease. Participants attending the live session can earn 2 ESMO-MORA Category 1 points.
URL:https://oncodaily.com/event/esmo-deep-dive-574943
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-04_23_56-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261022
DTEND;VALUE=DATE:20261025
DTSTAMP:20260826T124208Z
CREATED:20260826T124208Z
LAST-MODIFIED:20260826T124208Z
UID:10000959-1792627200-1792886399@oncodaily.com
SUMMARY:64th Annual Meeting of the Japan Society of Clinical Oncology (JSCO 2026)
DESCRIPTION:The 64th Annual Meeting of the Japan Society of Clinical Oncology (JSCO 2026) will take place on October 22–24\, 2026\, at the Kobe Convention Center in Kobe\, Japan.  \nHeld under the theme “One Team to Conquer Cancer\,” the meeting will bring together clinicians\, researchers\, medical staff\, and other professionals involved in cancer care for a broad multidisciplinary programme covering advances in cancer genomics\, immunotherapy\, robotic-assisted surgery\, artificial intelligence\, translational research\, biomarkers\, ctDNA-guided follow-up\, photoimmunotherapy\, and emerging approaches to immune checkpoint inhibitor treatment. \nThe programme will include 39 organ-specific sessions\, 33 interdisciplinary sessions\, and the JSCO Frontier initiative\, and the meeting will also be co-hosted with the 6th Annual Meeting of the Asian Oncology Society (AOS)\, including a joint JSCO/ASCO/ESMO/AOS session with international oncology leaders.
URL:https://oncodaily.com/event/japan-society-of-clinical-oncology-574949
LOCATION:Kobe Convention Center\, Kobe International Conference Center\, Kobe\, Hyogo Prefecture\, 650-0046\, Japan
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-04_41_16-PM.webp
ORGANIZER;CN="Japan Society of Clinical Oncology":MAILTO:tokyo-office@jsco.or,jp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261023T080000
DTEND;TZID=America/Halifax:20261023T170000
DTSTAMP:20261016T195652Z
CREATED:20261016T195652Z
LAST-MODIFIED:20261016T195652Z
UID:10001091-1792742400-1792774800@oncodaily.com
SUMMARY:OncoDaily Party 2026: Madrid Midnight
DESCRIPTION:The OncoDaily Party 2026: Madrid Midnight will bring together the global oncology community for an evening of connection\, music\, and celebration during ESMO 2026. Taking place at Gabana Madrid on October 23\, the event continues the OncoDaily Party tradition of bringing oncology professionals together beyond the congress halls\, creating a relaxed space to reconnect with colleagues\, meet new members of the community\, and celebrate the people moving oncology forward. \nFollowing previous OncoDaily parties in Chicago\, Barcelona\, and Berlin\, the Madrid edition will offer an opportunity to step away from the busy congress schedule and enjoy an evening surrounded by friends\, colleagues\, and members of the international oncology community. Guests can expect DJ sets\, conversations\, new connections\, and a lively atmosphere extending well into the night. \nAdmission is by invitation only.
URL:https://oncodaily.com/event/oncodaily-party-2026-601316
LOCATION:Gabana Madrid\, Calle de María de Molina\, 39\, Madrid\, Community of Madrid\, 28006\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_4574-2-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20280205
DTSTAMP:20260127T204055Z
CREATED:20250715T190605Z
LAST-MODIFIED:20260127T204055Z
UID:10000218-1792742400-1833296400@oncodaily.com
SUMMARY:The ESMO Congress 2026
DESCRIPTION:The ESMO Congress 2026 will take place from 23–27 October in Madrid\, Spain\, bringing together oncology professionals from around the world. \nThis global event serves as a key platform for presenting groundbreaking research\, advancing clinical practice\, and shaping patient care in oncology. Attendees can expect new data releases\, interactive educational sessions\, networking opportunities\, and an innovative exhibition area. \nLed by Congress President Fabrice André\, along with Scientific Co-Chairs Yelena Janjigian and James Larkin\, and Educational Chair Nadia Harbeck\, the congress will cover the latest developments across all areas of cancer care. By joining ESMO 2026\, participants contribute to global progress in oncology while staying up to date with the most relevant clinical and research advancements. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-329848
LOCATION:Madrid\, Madrid\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7216.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261023T130000
DTEND;TZID=America/Halifax:20261023T160000
DTSTAMP:20261005T132228Z
CREATED:20261005T132228Z
LAST-MODIFIED:20261005T132228Z
UID:10001090-1792760400-1792771200@oncodaily.com
SUMMARY:OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition
DESCRIPTION:OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition will take place on October 23\, 2026\, from 1:00 PM to 4:00 PM at the Novotel Madrid Feria and Airport in Madrid\, Spain. \nThe special live session will be held during the ESMO 2026 Congress and will continue the sarcoma-focused discussion following the successful Sarcoma Grand Rounds held during ASCO 2026. \nThe session will bring together leading experts in sarcoma to discuss developments shaping the field and explore how emerging evidence may influence treatment strategies and future directions in sarcoma care. The program will be co-chaired by Prof. Robin Jones and Prof. Javier Martín-Broto. \nJust 2 minutes’ walk from IFEMA Madrid\, the event is designed as an opportunity for experts to continue the conversation around advances in sarcoma during ESMO 2026.
URL:https://oncodaily.com/event/oncodaily-grand-rounds-601296
LOCATION:Novotel Madrid Feria and Airport\, Calle de Ámsterdam\, 3\, Campo de las Naciones\, Madrid\, Community of Madrid\, 28042\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/10-5-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261024T133000
DTEND;TZID=America/Halifax:20261024T163000
DTSTAMP:20261016T201951Z
CREATED:20261016T201951Z
LAST-MODIFIED:20261016T201951Z
UID:10001105-1792848600-1792859400@oncodaily.com
SUMMARY:OncoDaily – Who Owns the Message Brunch during ESMO 2026
DESCRIPTION:Who Owns the Message Brunch during ESMO 2026\, organized by OncoDaily\, will take place on October 24\, 2026\, at Club de Golf Olivar de la Hinojosa in Madrid\, Spain. \nThe invitation-only brunch will bring together a select group of senior communications\, corporate affairs\, public affairs\, and marketing leaders from the pharmaceutical and healthcare industry for an intimate discussion about the changing landscape of healthcare communication. \nAs scientific information moves faster\, audiences become increasingly fragmented\, patients gain a stronger voice\, social media can reshape narratives within hours\, and artificial intelligence changes how information is created and consumed\, healthcare communication is becoming increasingly complex. The brunch will provide a space for leaders to step outside formal presentations and openly discuss the challenges they face while balancing scientific accuracy\, corporate reputation\, regulatory requirements\, stakeholder expectations\, and trust. \nRather than a traditional conference or networking event\, Who Owns the Message? is designed as a candid conversation about who shapes healthcare narratives today\, how different stakeholders influence communication\, and how the industry can build more effective\, trusted\, and impactful approaches to communicating about healthcare and science. \n 
URL:https://oncodaily.com/event/esmo-2026-609951
LOCATION:Club de Golf Olivar de la Hinojosa\, Vía de Dublín\, S/N\, Madrid\, Community of Madrid\, 28042\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_4280-1-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261024T181500
DTEND;TZID=America/Halifax:20261024T201500
DTSTAMP:20261005T133159Z
CREATED:20261005T133159Z
LAST-MODIFIED:20261005T133159Z
UID:10001092-1792865700-1792872900@oncodaily.com
SUMMARY:OncoDaily – Big Questions During ESMO 2026
DESCRIPTION:OncoDaily – Big Questions During ESMO 2026 will take place on October 24\, 2026\, from 6:15 PM to 8:15 PM in Madrid\, Spain\, during the ESMO 2026 Congress. \nThe session\, chaired by Prof. Jean-Yves Blay\, will bring together clinicians\, clinical trialists\, researchers\, regulators\, policymakers\, patient advocates\, and other oncology leaders for an open discussion of the decisions that shape cancer research\, drug development\, regulation\, and patient access. \nRather than a traditional lecture programme\, the event will centre on a moderated two-hour panel discussion\, with dedicated time for audience questions and participation. The discussion will examine how different stakeholders approach critical decisions across the oncology ecosystem and where perspectives align or diverge. \nKey topics will include the fragility of clinical evidence\, what happens when important trials end prematurely\, how much uncertainty should be accepted in regulatory approvals\, the divide between regulatory and clinical interpretation of evidence\, and the persistent gap between a treatment being approved and actually becoming available to patients. \nThe panel will also explore questions around research funding\, trial continuation and closure\, commercially unattractive research questions\, evidence thresholds for changing clinical practice\, health economics\, reimbursement\, and equitable access to cancer treatments.
URL:https://oncodaily.com/event/big-questions-during-esmo-2026-601323
LOCATION:Madrid\, Madrid\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_4005-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261025T140000
DTEND;TZID=America/Halifax:20261025T180000
DTSTAMP:20261016T203111Z
CREATED:20261016T203111Z
LAST-MODIFIED:20261016T203111Z
UID:10001106-1792936800-1792951200@oncodaily.com
SUMMARY:OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition
DESCRIPTION:OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition will take place on October 25\, 2026\, at Novotel Madrid Feria and Airport in Madrid\, Spain. \nChaired by Prof. Andrea Necchi\, this one-day\, in-person event will bring together international experts to discuss the scientific developments\, clinical questions\, and practical treatment decisions shaping bladder cancer care. \nThe programme will combine expert presentations\, interactive faculty discussions\, live polling\, and audience participation. The first part\, “Expert Perspectives: What Would You Do?”\, will address treatment approaches in localised bladder cancer\, advanced urothelial carcinoma\, treatment selection and sequencing\, toxicity\, patient preferences\, and multidisciplinary decision-making. \nThe second part\, “One Clinical Scenario\, Different Countries\,” will bring together international faculty to explore how guidelines\, treatment access\, available resources\, and local healthcare settings influence bladder cancer management across different countries. \n 
URL:https://oncodaily.com/event/bladder-cancer-edition-609963
LOCATION:Novotel Madrid Feria and Airport\, Calle de Ámsterdam\, 3\, Campo de las Naciones\, Madrid\, Community of Madrid\, 28042\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/10/IMG_4462-1-2.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261106T090000
DTEND;TZID=America/Halifax:20261106T183000
DTSTAMP:20260826T125827Z
CREATED:20260826T125827Z
LAST-MODIFIED:20260826T125827Z
UID:10000960-1793955600-1793989800@oncodaily.com
SUMMARY:The 7th ESMO in the Alps
DESCRIPTION:The 7th ESMO in the Alps will take place on November 6\, 2026\, from 9:00 AM to 6:30 PM at KKL Luzern in Lucerne\, Switzerland. \nThe event will bring key highlights and practice-changing studies from the ESMO Congress 2026 to a Swiss oncology audience\, combining original congress videos with live discussion involving local experts and original authors. \nThe programme will cover major areas including genitourinary cancer\, breast and gynecologic cancers\, gastrointestinal cancer\, lung cancer\, and other hot topics\, with an emphasis on current standards of care\, interpretation of new evidence\, and practical take-home messages. \nParticipants can attend on site or via webinar\, with networking opportunities available for in-person attendees. The course is held under the auspices of the CPTC network of the Swiss Cancer Institute.
URL:https://oncodaily.com/event/the-7th-esmo-in-the-alps-574969
LOCATION:KKL Luzern – Kultur- und Kongresszentrum Luzern\, Europaplatz 1\, Lucerne\, Lucerne\, 6005\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/esmo-1-1.webp
ORGANIZER;CN="medtoday Switzerland / Swiss Cancer Institute":MAILTO:info@medtoday.ch
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261111
DTEND;VALUE=DATE:20261113
DTSTAMP:20260127T203943Z
CREATED:20260127T203943Z
LAST-MODIFIED:20260127T203943Z
UID:10000635-1794355200-1794527999@oncodaily.com
SUMMARY:ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona
DESCRIPTION:The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona\, Spain\, from November 11–12\, 2026. \nThis specialized educational program is co-chaired by Simon Ekman\, Lizza Hendriks\, and Natasha Leighl\, and focuses on providing oncologists with high-level training on the evolving diagnostic and therapeutic strategies for brain metastases originating from lung and breast malignancies. The course is designed to address the clinical challenges of managing central nervous system involvement\, highlighting the latest research\, systemic therapies\, and multidisciplinary approaches essential for optimizing patient outcomes in these complex cases. \nApplication.
URL:https://oncodaily.com/event/brain-metastases-448007
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-8.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261113
DTEND;VALUE=DATE:20261115
DTSTAMP:20260826T134459Z
CREATED:20260826T134459Z
LAST-MODIFIED:20260826T134459Z
UID:10000961-1794528000-1794700799@oncodaily.com
SUMMARY:The ESMO Advanced Course on Cholangiocarcinoma 2026
DESCRIPTION:The ESMO Advanced Course on Cholangiocarcinoma 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 13–14\, 2026\, in Barcelona\, Spain. \nThe course is designed to provide an advanced multidisciplinary update on the diagnosis and management of cholangiocarcinoma\, covering diagnostic challenges\, clinical and molecular differences between disease subtypes\, adjuvant and palliative treatment strategies\, surgery and other locoregional therapies\, immunotherapy\, and currently available and emerging targeted treatments for advanced disease. \nThe programme is aimed at oncology professionals seeking deeper practical knowledge of this complex malignancy and has been accredited with 11 ESMO-MORA Category 1 points.
URL:https://oncodaily.com/event/advanced-course-on-cholangiocarcinoma-574980
LOCATION:Barcelona\, Barcelona\, Catalonia\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-05_12_07-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261116
DTEND;VALUE=DATE:20261119
DTSTAMP:20251127T193815Z
CREATED:20251127T193756Z
LAST-MODIFIED:20251127T193815Z
UID:10000412-1794787200-1795046399@oncodaily.com
SUMMARY:ESMO AI and Digital Oncology Congress 2026
DESCRIPTION:The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18\, 2026\, in Berlin\, Germany. \nThis congress is designed as a central meeting point that facilitates the exchange of the latest research\, promotes ethical dialogue\, and highlights technological innovation in cancer care. \nIt brings together healthcare and digital health experts from around the world to foster collaboration\, inspire learning\, and empower oncology professionals to stay ahead in the rapidly evolving digital transformation of medicine. \nThe specific congress venue within Berlin is expected to be announced on the official European Society for Medical Oncology (ESMO) website closer to the event date.
URL:https://oncodaily.com/event/esmo-417477
LOCATION:Berlin\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261118T183000
DTEND;TZID=America/Halifax:20261118T183000
DTSTAMP:20260905T151650Z
CREATED:20260905T151650Z
LAST-MODIFIED:20260905T151650Z
UID:10000996-1795026600-1795026600@oncodaily.com
SUMMARY:ESMO Deep Dive: Are We Defeating Cervical Cancer?
DESCRIPTION:The ESMO Deep Dive: Gynaecological Cancers – Are We Defeating Cervical Cancer? 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 18\, 2026\, at 6:30 PM CET (9:30 PM AMT) as a live virtual webinar. \nThe session will review recent progress and remaining challenges in cervical cancer management\, including pembrolizumab combined with concurrent chemoradiation for locally advanced disease\, the role of immune checkpoint inhibitors in recurrent or metastatic cervical cancer\, and treatment options after progression on immunotherapy. \nThe expert discussion will examine how these developments are changing clinical practice and what questions remain as systemic treatment strategies continue to evolve. Participants attending the live session can earn 2 ESMO-MORA Category 1 points.
URL:https://oncodaily.com/event/esmo-deep-dive-581188
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-5-2026-07_13_26-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261125
DTEND;VALUE=DATE:20261127
DTSTAMP:20260903T202512Z
CREATED:20260903T202437Z
LAST-MODIFIED:20260903T202512Z
UID:10000992-1795564800-1795737599@oncodaily.com
SUMMARY:ESMO Advanced Course on Endocrine Sensitivity in HR+/HER2− Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Advanced Course on Defining Endocrine Sensitivity & Optimising Treatment Strategies in HR+/HER2− mBC Patients 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 25\, 2026\, in Barcelona\, Spain. \nThe course will focus on the increasingly complex management of hormone receptor-positive\, HER2-negative metastatic breast cancer\, particularly how clinicians define endocrine sensitivity and resistance and use these distinctions to guide treatment decisions. \nThe programme is designed to support evidence-based therapeutic selection and sequencing as treatment options for HR+/HER2− metastatic disease continue to expand\, with emphasis on integrating clinical and molecular information into individualized patient management.
URL:https://oncodaily.com/event/endocrine-sensitivity-580276
LOCATION:Barcelona\, Barcelona\, Catalonia\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-4-2026-12_22_08-AM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261127
DTEND;VALUE=DATE:20261128
DTSTAMP:20260826T141815Z
CREATED:20260826T141815Z
LAST-MODIFIED:20260826T141815Z
UID:10000962-1795737600-1795823999@oncodaily.com
SUMMARY:The Best of ESMO Baltic 2026 Conference
DESCRIPTION:The Best of ESMO Baltic 2026 conference will take place on November 27\, 2026\, in Riga\, Latvia\, bringing together oncology specialists from Latvia\, Estonia\, Lithuania\, and other countries to review key findings and clinical highlights from the latest ESMO Congress. \nThe programme will focus on translating important new evidence into everyday oncology practice through expert presentations\, discussion\, and exchange of experience among regional and international specialists. \nThe meeting is primarily intended for oncologists and chemotherapy specialists and can be attended either in person or remotely. All participants will receive an 8-hour qualification certificate. The conference is organized by the Latvian Association of Oncologist Chemotherapists\, in close collaboration with the relevant Estonian and Lithuanian societies.
URL:https://oncodaily.com/event/esmo-baltic-2026-conference-575045
LOCATION:Radisson Blu Latvija Conference & Spa Hotel\, Elizabetes iela 55\, Riga\, Riga\, LV-1010\, Latvia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ESMO2026_1200x628-1-03a0716d-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261204
DTEND;VALUE=DATE:20261207
DTSTAMP:20260105T000508Z
CREATED:20260105T000502Z
LAST-MODIFIED:20260105T000508Z
UID:10000552-1796342400-1796601599@oncodaily.com
SUMMARY:ESMO Asia Congress 2026
DESCRIPTION:The ESMO Asia Congress 2026 is the premier scientific platform in the Asia-Pacific region for oncology professionals\, scheduled for December 4-6\, 2026\, in Singapore. \nOrganized by the European Society for Medical Oncology (ESMO)\, this major international congress brings together global experts and regional leaders to present the latest research and clinical data across all major tumor types. \nThe technical program features high-level scientific symposia\, educational sessions on state-of-the-art treatments\, and a dedicated Young Oncologists track aimed at fostering the next generation of cancer researchers. The event emphasizes regional specificities in cancer management and promotes collaborative research to improve patient outcomes throughout Asia.
URL:https://oncodaily.com/event/esmo-asia-436785
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard Singapore\, Singapore\, 039593\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Asia-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261214
DTEND;VALUE=DATE:20261217
DTSTAMP:20251211T194040Z
CREATED:20251211T193956Z
LAST-MODIFIED:20251211T194040Z
UID:10000476-1797206400-1797465599@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2026
DESCRIPTION:The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO)\, scheduled for December 14–16\, 2026\, as an onsite event in London\, United Kingdom\, with an online option also available. \nThe congress serves as a critical platform for exchanging knowledge and fostering collaboration in immuno-oncology\, covering the entire spectrum of the field from basic science to translational research and clinical development. The meeting will feature the latest scientific advances\, offering researchers\, clinicians\, and other stakeholders excellent opportunities to interact\, share expertise\, and engage with the global community committed to advancing cancer care through innovation.
URL:https://oncodaily.com/event/immuno-oncology-426416
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-IO-2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR